跳至主要内容
临床试验/NCT01132131
NCT01132131已完成4 期

Use of Standardized Delegation Form in Diagnosing and Treating Acute Cystitis in Primary Care Facilities.

University of Oslo2 个研究点 分布在 1 个国家目标入组 443 人开始时间: 2010年8月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
443
试验地点
2
主要终点
Number of patients who are clinically and symptomatologically free of symptoms.

研究概览

简要总结

The Emergency Ward Center in Oslo has the last two years used a questionnaire to identify patients who qualify for treatment of acute cystitis by the use of a delegation form.

The aim of the study is to evaluate this practice, the primary objective being to evaluate if in a selected patient group the treatment outcome after identifying patients with probable acute cystitis by delegation form will be as good or better than the treatment received after a regular doctor's consultation.

The planned study will also investigate which symptoms, signs and laboratory findings that coincide with significant bacteruria.

The reference standard will be a microbiological culture of every patients urine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 55 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Females 16-55 years
  • Increased frequency of urination

排除标准

  • Breastfeeding child < 1 month of age
  • Kidney disease
  • Poor general condition
  • Abdominal pain
  • Increased amount of vaginal secretions
  • Vaginal itching or pain
  • Urinary tract infection in the last four weeks
  • Use of urinary catheter in the last four weeks
  • Symptoms lasting more than seven days
  • Ongoing antibiotic treatment
  • Allergy to penicillin
  • Use of the medicine Probecid

研究组 & 干预措施

Delegation form

Active Comparator

干预措施: Delegation form (Other)

Regular doctor's consultation

Active Comparator

干预措施: Delegation form (Other)

结局指标

主要结局

Number of patients who are clinically and symptomatologically free of symptoms.

时间窗: 10 days after start of treatment

The antibiotic treatment will be of three days length

Number of patients who are clinically and bacteriologically free of symptoms of urinary tract infection.

时间窗: 6 days after start of treatment.

The antibiotic treatment given will be of three days length.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marianne Bollestad

Md

University of Oslo

研究点 (2)

Loading locations...

相似试验